|
|
Other links at Articles > Nephrology |
| 2. |
Valganciclovir Curbs CMV in Kidney Recipients
|
|
|
Human cytomegalovirus (CMV) prophylaxis using valganciclovir in CMV-seropositive kidney-transplant patients is effective in disease prevention, according to French researchers. Reuters Health Information
|
|
|